Email this article Updates in urologic oncology guidelines: urothelial carcinoma. A review
- Authors: Volkova M.I.1,2, Alekseev B.Y.3,4, Gladkov O.A.5
-
Affiliations:
- Russian Medical Academy of Continuous Professional Education
- City Clinical Oncology Hospital №1
- Russian Biotechnological University
- National Medical Research Radiological Centre
- Oncology Clinic EVIMED
- Issue: Vol 25, No 2 (2023)
- Pages: 155-158
- Section: CLINICAL ONCOLOGY
- URL: https://journals.rcsi.science/1815-1434/article/view/132812
- DOI: https://doi.org/10.26442//18151434.2023.2.202105
- ID: 132812
Cite item
Full Text
Abstract
Guidelines for drug therapy of urothelial cancer (UC) have had several significant updates since new data from clinical studies became available and due to updates of labels for certain drugs approved for this indication in the Russian Federation. Opinions of expert panels developing clinical guidelines of the Ministry of Health of Russia and practical guidelines of the Russian Society of Clinical Oncology (RUSSCO) were divided over several positions. The article presents the key points of these updates.
Full Text
##article.viewOnOriginalSite##About the authors
Maria I. Volkova
Russian Medical Academy of Continuous Professional Education; City Clinical Oncology Hospital №1
Author for correspondence.
Email: mivolkova6@gmail.com
ORCID iD: 0000-0001-7754-6624
D. Sci. (Med.)n Medical Academy of Continuous Professional Education, doctor of oncology department No. 8
Russian Federation, Moscow; MoscowBoris Ya. Alekseev
Russian Biotechnological University; National Medical Research Radiological Centre
Email: mivolkova6@gmail.com
ORCID iD: 0000-0002-3398-4128
D. Sci. (Med.), Prof.n Biotechnological University
Russian Federation, Moscow; MoscowOleg A. Gladkov
Oncology Clinic EVIMED
Email: mivolkova6@gmail.com
ORCID iD: 0000-0003-1367-2079
D. Sci. (Med.), center director Oncology Clinic
Russian Federation, ChelyabinskReferences
- Гладков О.А., Зуков Р.А., Матвеев В.Б., и др. Практические рекомендации по лекарственному лечению рака мочевого пузыря. Злокачественные опухоли: Практические рекомендации RUSSCO #3s2. 2022;12:589-606 [Gladkov OA, Zukov RA, Matveev VB, et al. Prakticheskiie rekomendatsii po lekarstvennomu lecheniyu raka mochevogo puzyria. Zlokachestvennyie opukholi: Prakticheskiie rekomendatsii RUSSCO #3s2. 2022;12:589-606 (in Russian)].
- Клинические рекомендации МЗ РФ. Рак мочевого пузыря. Режим доступа: https://old.oncology-association.ru/clinical-guidelines-update. Ссылка активна на 10.12.2022 [Clinical recommendations of the Ministry of Health of the Russian Federation. Bladder cancer. Available at: https://old.oncology-association.ru/clinical-guidelines-update. Accessed: 10.12.2022 (in Russian)].
- Клинические рекомендации МЗ РФ. Уротелиальный рак верхних мочевыводящих путей. Режим доступа: https://old.oncology-association.ru/clinical-guidelines-update. Ссылка активна на 10.12.2022 [Clinical recommendations of the Ministry of Health of the Russian Federation. Urothelial cancer of the upper urinary tract. Available at: https://old.oncology-association.ru/clinical-guidelines-update. Accessed: 10.12.2022 (in Russian)].
- Клинические рекомендации МЗ РФ. Рак уретры. Режим доступа: https://old.oncology-association.ru/clinical-guidelines-update. Ссылка активна на 10.12.2022 [Clinical recommendations of the Ministry of Health of the Russian Federation. Urethral cancer. Available at: https://old.oncology-association.ru/clinical-guidelines-update. Accessed: 10.12.2022 (in Russian)].
